GENFIT (EPA:GNFT) | WebDisclosure

Basculer en Français

10368	Companies
215967	Keywords
145708	Articles
114374	Press releases

Home
Companies
GENFIT

PRESS RELEASE

published on 09/22/2025 at 19:06, 7 months 15 days ago

Attestation de la personne responsable associée au rapport d'activité et financier semestriel 2025
Attestation de conformité des comptes consolidés pour le semestre écoulé de GEIXIFIT. Pascal Prigent, Directeur Général, certifie l'image fidèle du patrimoine et des activités de l'entreprise

Comptes Consolidés Conformité Attestation GEIXIFIT Pascal Prigent
PRESS RELEASE

published on 09/22/2025 at 19:02, 7 months 15 days ago

Rapport des CAC associé au rapport d'activité et financier semestriel 2025
BRIEF

published on 09/19/2025 at 22:15, 7 months 18 days ago

GENFIT refocuses the development of VS-01 on a new pathology

Biopharmaceutical GENFIT ACLF VS-01 UCD
BRIEF

published on 09/19/2025 at 22:15, 7 months 18 days ago

GENFIT recentre le développement de VS-01 sur une nouvelle pathologie

Biopharmaceutique GENFIT ACLF VS-01 UCD
PRESS RELEASE

published on 09/19/2025 at 22:10, 7 months 18 days ago

GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCD
GENFIT discontinues VS-01 program in ACLF and shifts focus to UCD due to safety concerns. The company aims to accelerate other assets in ACLF, while exploring CCA data and reducing operating expenses

Clinical Trials GENFIT ACLF VS-01 UCD
PRESS RELEASE

published on 09/19/2025 at 22:10, 7 months 18 days ago

GENFIT annonce l'arrêt de son programme VS-01 dans l'ACLF – le développement de VS-01 est recentré sur l'UCD
GENFIT annonce l'arrêt de son programme VS-01 dans l'ACLF et se recentre sur l'UCD pour traiter les troubles du cycle de l'urée. L'arrêt fait suite à un événement indésirable grave dans l'essai clinique UNVEIL-IT®

GENFIT ACLF VS-01 UCD Troubles Du Cycle De L'urée
BRIEF

published on 07/08/2025 at 22:15, 9 months 30 days ago

GENFIT annonce son contrat de liquidité semestriel avec le Crédit Industriel et Commercial

Biopharmaceutique Crédit Industriel Maladies Du Foie Liquidité De GENFIT Négociations 2025
BRIEF

published on 07/08/2025 at 22:15, 9 months 30 days ago

GENFIT Reports on Half-Year Liquidity Contract with Crédit Industriel et Commercial

Biopharmaceutical Liver Diseases Crédit Industriel GENFIT Liquidity 2025 Trading
PRESS RELEASE

published on 07/08/2025 at 22:10, 9 months 30 days ago

Genfit: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
GENFIT announces half-year report of liquidity contract with Crédit Industriel et Commercial, detailing trading activities and resources as of June 30, 2025

Liquidity Contract Financial Report Crédit Industriel Et Commercial Trading Activities GENFIT
PRESS RELEASE

published on 07/08/2025 at 22:10, 9 months 30 days ago

Genfit : Bilan semestriel du contrat de liquidité contracté avec le Crédit Industriel et Commercial
GENFIT annonce le bilan semestriel de son contrat de liquidité avec le Crédit Industriel et Commercial, incluant les transactions et moyens de liquidité au 30 juin 2025

Contrat De Liquidité Bilan Semestriel Transactions Crédit Industriel Et Commercial GENFIT

Accesswire

Published on 05/08/2026 at 00:45, 1 hour 11 minutes ago

Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 1 hour 56 minutes ago

Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 2 hours 26 minutes ago

Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 2 hours 41 minutes ago

BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/07/2026 at 22:05, 3 hours 51 minutes ago

MicroVision and Avular Collaborate to Advance Autonomous Sensing and Drone Integration for Next-Generation Infrastructure Applications

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 23:23, 2 hours 32 minutes ago

H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 2 hours 41 minutes ago

EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 3 hours 51 minutes ago

Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 5 hours 13 minutes ago

RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 7 hours 10 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/07/2026 at 19:15, 6 hours 41 minutes ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 6 hours 41 minutes ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 6 hours 50 minutes ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 6 hours 50 minutes ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 6 hours 56 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE